Bioconjugate technique for site-specific attachment of IgG onto nanoparticles

将 IgG 定点附着到纳米粒子上的生物共轭技术

基本信息

  • 批准号:
    8822592
  • 负责人:
  • 金额:
    $ 24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-26 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Antibodies, most commonly IgGs, have been widely used as targeting ligands in research and therapeutic applications due to their wide array of targets, high specificity and proven efficacy. Many of these applications require antibodies to be conjugated onto surfaces (e.g. nanoparticles and microplates); however, most conventional bioconjugation techniques (e.g. EDC-NHS) exhibit low crosslinking efficiencies, hinder functionality due to non-site-specific labeling, and/or require protein engineering (e.g. cysteine handles), which can be technically challenging and time consuming. This can result in high costs, heteregeneous samples, and poor reproducibility. To overcome these limitations, we will recombinantly express Protein Z, which binds the Fc region of IgG, with an UV active non-natural amino acid benzoylphenyalanine (BPA) within its binding domain. Upon exposure to long wavelength UV light, the BPA will be activated and form a covalent link between the Protein Z and the bound Fc region of IgG. This technology will be combined with expressed protein ligation (EPL), which will allow for the introduction of a fluorophore and click compatible azide group onto the C-terminus of Protein Z during the recombinant protein purification step. This will enable crosslinked- Protein Z-IgG complexes to be efficiently and site-specifically attached to aza-dibenzycyclooctyne-modified microplates and nanoparticles, via copper-free click chemistry. This approach is cost-effective, easily scalable, and utilizes protein production techniques that are commercially viable. Site-specific labeling has not only been shown to improve the activity of various surface-bound antibody conjugates (e.g. immunoassays and nanoparticles) but also non-surface bound antibody conjugates (e.g. antibody-drug conjugates) and thus the approach proposed here is expected to have broad applicability. The specific aims for the proposal are (1) Optimize the yield of photoreactive Protein Z expression and the efficiency of expressed protein ligation; (2) Optimize the photo-crosslinking efficiency between Protein Z and various IgG subtypes.
描述(由申请人提供):抗体,最常见的是igg,由于其广泛的靶标,高特异性和已证实的功效,已被广泛用作研究和治疗应用的靶向配体。许多这些应用需要将抗体偶联到表面(例如纳米颗粒和微孔板);然而,大多数传统的生物偶联技术(如EDC-NHS)表现出低交联效率,由于非位点特异性标记而阻碍功能,和/或需要蛋白质工程(如半胱氨酸把手),这在技术上具有挑战性且耗时。这可能导致成本高、样品不均匀和再现性差。为了克服这些限制,我们将重组表达结合IgG Fc区的蛋白Z,并在其结合区域内含有一个具有紫外线活性的非天然氨基酸苯甲酰苯丙氨酸(BPA)。在长波长紫外线照射下,BPA会被激活,并在蛋白Z和IgG结合的Fc区之间形成共价键。这项技术将与表达蛋白连接(EPL)相结合,这将允许引入荧光团和点击兼容

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Tsourkas其他文献

Andrew Tsourkas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Tsourkas', 18)}}的其他基金

Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
磁泳与光动力联合治疗TNBC
  • 批准号:
    10426358
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
磁泳与光动力联合治疗TNBC
  • 批准号:
    10586052
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
磁泳与光动力联合治疗TNBC
  • 批准号:
    10297166
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Image-guided surgery and sonodynamic therapy with stroma-targeted theranostic nanoclusters
使用基质靶向治疗诊断纳米簇进行图像引导手术和声动力治疗
  • 批准号:
    10541160
  • 财政年份:
    2020
  • 资助金额:
    $ 24万
  • 项目类别:
Image-guided surgery and sonodynamic therapy with stroma-targeted theranostic nanoclusters
使用基质靶向治疗诊断纳米簇进行图像引导手术和声动力治疗
  • 批准号:
    9886512
  • 财政年份:
    2020
  • 资助金额:
    $ 24万
  • 项目类别:
Image-guided surgery and sonodynamic therapy with stroma-targeted theranostic nanoclusters
使用基质靶向治疗诊断纳米簇进行图像引导手术和声动力治疗
  • 批准号:
    10318642
  • 财政年份:
    2020
  • 资助金额:
    $ 24万
  • 项目类别:
Modular approach for the delivery of antibodies into the cytoplasm of cells
将抗体递送到细胞质中的模块化方法
  • 批准号:
    9975797
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:
Modular approach for the delivery of antibodies into the cytoplasm of cells
将抗体递送到细胞质中的模块化方法
  • 批准号:
    10414929
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:
Modular approach for the delivery of antibodies into the cytoplasm of cells
将抗体递送到细胞质中的模块化方法
  • 批准号:
    10218119
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:
Modular approach for the delivery of antibodies into the cytoplasm of cells
将抗体递送到细胞质中的模块化方法
  • 批准号:
    10654576
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 24万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 24万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 24万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 24万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了